Overview
- 10 inspections across 9 sites are on record.
- 11 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-02-28.
At a glance
Inspections
10
Sites
9
Observations
11
Career since
Jan 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sparhawk Laboratories, Inc. | 28 Feb 2020 | Animal Drugs & Feeds | On file |
| Sparhawk Laboratories, Inc. | 28 Feb 2020 | Animal Drugs & Feeds | On file |
| Apertus Pharmaceuticals | 16 Jan 2020 | Human Drugs | On file |
| Marcus Research Laboratory, Inc. | 6 Dec 2019 | Human Drugs | On file |
| SpecGx LLC | 12 Sep 2019 | Human Drugs | On file |
Sites inspected
Sparhawk Laboratories, Inc.Lenexa, United States2 insp.
Apertus PharmaceuticalsBallwin, United States1 insp.
Marcus Research Laboratory, Inc.Saint Louis, United States1 insp.
SpecGx LLCSaint Louis, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Robert J Ham4 shared
James K Rice2 shared
Laura S Huffman2 shared
Michele Perry-Williams2 shared
Michele L Glendenning1 shared
Sarah E Rhoades1 shared
Michele L Obert1 shared
Wayne D Mcgrath1 shared
Edward E Lockwood1 shared
Full investigator report
Get the verbatim findings behind Ana Paula P Sandee's 11 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site